VEGFR-3 and Its Ligand VEGF-C Are Associated with Angiogenesis in Breast Cancer
- 1 May 1999
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 154 (5) , 1381-1390
- https://doi.org/10.1016/s0002-9440(10)65392-8
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Role of vascular endothelial growth factor in the regulation of angiogenesisKidney International, 1999
- Expression of the Vascular Endothelial Growth Factor C Receptor VEGFR-3 in Lymphatic Endothelium of the Skin and in Vascular TumorsThe American Journal of Pathology, 1998
- Hyperplasia of Lymphatic Vessels in VEGF-C Transgenic MiceScience, 1997
- Predictors of axillary lymph node metastases in patients with T1 breast carcinomaCancer, 1997
- Transmural Coupling of Fluid Flow in Microcirculatory Network and Interstitium in TumorsMicrovascular Research, 1997
- The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological ActivitiesJournal of Biological Chemistry, 1996
- A novel in situ hybridization signal amplification method based on the deposition of biotinylated tyramine.Journal of Histochemistry & Cytochemistry, 1995
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Tumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast CarcinomaJNCI Journal of the National Cancer Institute, 1992
- Delivery of Novel Therapeutic Agents in Tumors: Physiological Barriers and StrategiesJNCI Journal of the National Cancer Institute, 1989